Open AccessPhase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis
Author(s) -
Andrew Blauvelt,
Steven Kempers,
Edward Lain,
Todd Schlesinger,
Stephen K. Tyring,
Seth Forman,
Glynis Ablon,
George M. Martin,
Hui Wang,
David L. Cutler,
Jane Fang,
Min-Fun Rudolf Kwan
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2024040
Subject(s) - actinic keratosis , dermatology , basal cell , medicine , keratosis , actinic keratoses , cancer research
The tubulin polymerization and Src kinase signaling inhibitor tirbanibulin is being investigated as a topical treatment for actinic keratosis, a precursor of squamous-cell carcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom